13 articles for GJ Hollingworth
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Cmpds
Data
Article Title
Organization
16
Discovery of novel pyrrolidineoxy-substituted heteroaromatics as potent and selective PI3K delta inhibitors with improved physicochemical properties.
Novartis Institutes For Biomedical Research
13
Discovery of New Binders for DCAF1, an Emerging Ligase Target in the Targeted Protein Degradation Field.
Novartis Institutes for Biomedical Research
12
Novel lactam NK1 antagonists with anti-emetic activity.
Merck Sharp & Dohme Research Laboratories
28
Discovery and Toxicological Profiling of Aminopyridines as Orally Bioavailable Selective Inhibitors of PI3-Kinase γ.
Novartis Institutes For Biomedical Research
16
4,4-Disubstituted cyclohexylamine NK(1) receptor antagonists II.
Merck Sharp & Dohme Research Laboratories
19
4,4-Disubstituted cyclohexylamine NK(1) receptor antagonists I.
Merck Sharp & Dohme Research Laboratories
27
2-Aryl indole NK1 receptor antagonists: optimisation of the 2-aryl ring and the indole nitrogen substituent.
Merck Sharp and Dohme Research Laboratories
27
2-Aryl indole NK1 receptor antagonists: optimisation of indole substitution.
The Neuroscience Research Centre
16
Discovery and Pharmacological Characterization of Novel Quinazoline-Based PI3K Delta-Selective Inhibitors.
Novartis Institutes For Biomedical Research
12
Discovery of CDZ173 (Leniolisib), Representing a Structurally Novel Class of PI3K Delta-Selective Inhibitors.
Novartis Institutes For Biomedical Research
7
Pharmaceutical uses of 6-amino quinazoline or 3-cyano quinoline derivatives
Jiangsu Hengrui Medicine
4
-Hydroxyacyl-acyl Carrier Protein Dehydratase (FabZ) from Francisella tularensis and Yersinia pestis: Structure Determination, Enzymatic Characterization, and Cross-Inhibition Studies.
Brookhaven National Laboratory